VIDAS D-Dimer Exclusion, based on clinical management studies,
has been cleared by the FDA for the exclusion of DVT and
PE as a diagnosis in outpatients, in conjunction with a
pretest probability assement model.
Pathologies
No.
of Patients
Negative
Predictive Value (NPV) %
References
PE
and DVT
918
99.3
Perrier
A, et al., Lancet, 1999, 353: 190-5
PE
and DVT
100
100
Freyburger
G, et al., Thromb Haemost, 1998, 79:32-7
DVT
132
100
Jansen
MCH, et al., Thromb Haemost, 1997, 77: 262-6
DVT
103
98
D’Angelo
A, et al., Thromb Haemost, 1996, 75: 412-16
PE
195
100
De
Moerloose P, et al., Thromb Haemost, 1996, 75: 11-13
PE
965
100
Perrier
A, et al. Amer J of Med. 2004, 116: 291-29
PE
and DVT
Meta
Analysis
Stein
PD, et al. Annals of Int. Med.
DVT
302
100
De
Moerloose P, Thromb Haemost, 2001, 85: 185 - 186
For more references and the package insert, please visit
our Technical
Library.
